Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Authorities Finally Discover Proof of the Real Author of Shakespeare's Works
  • USA - English


News provided by

[email protected]

Feb 08, 2017, 03:00 ET

Share this article

Share toX

Share this article

Share toX

The story of the greatest literary conspiracy of all time
The story of the greatest literary conspiracy of all time

Palm Springs, CA (PRWEB) February 08, 2017 -- Two recent discoveries, one in England and one in America, have finally determined the real author of the works of Shakespeare.

Both discoveries coincided with the 400th anniversary of the death of the actor from Stratford who for centuries has been credited with writing the plays and poems. These announcements have fanned the flames of the daily stories resurrecting the usual authorship candidates – Marlowe, Bacon, the Earl of Oxford and even the actor Shakespeare himself.

"Dead men don't write plays -- not even Shakespeare."

Post this

In 2016, the “New Oxford Complete Works of Shakespeare” (one of the most authoritative scholarly resources concerning Shakespeare’s writings) listed Christopher Marlow as the co-author of some of the plays, including “Henry VI, (Parts One, Two and Three.”) An esteemed team of 23 scholars from five countries completed the research on this.

According to The London Guardian, these three plays are among the 17 or more that are now believed to be written by someone other than Shakespeare.

The New York Times wrote “This is the first time another author has been listed on the title page of any of Shakespeare’s works.”

The second discovery came in the same year from a team of Americans at Pennsylvania State University. The analysts at Penn State corroborated the work in England and even credited Marlowe with penning the famous line, “First thing we do, let’s kill all the lawyers” in Henry VI, Part 2.

So, finally we learn that dead men don’t write plays, at least according to The Shakespeare Conspiracy, a book by Ted Bacino.

Fourteen of the Bard’s plays were all written after 1616, the year Shakespeare, the actor from Stratford, died. According to a character in Bacino’s novel, “Some playwrights don’t write that many plays in a whole lifetime and certainly not after they’ve died.”

Two questions have plagued historians for hundreds of years. How could Christopher Marlowe, a known spy and England’s foremost playwright be suspiciously murdered and quickly buried in an unmarked grave – just days before he was to be tried for treason?

And, secondly, how could William Shakespeare, an unknown actor who sometimes held horses for the gentry while they watched the plays, suddenly burst onto the scene writing these beautiful masterpieces when he had never written anything before?

According to Bacino’s novel The Shakespeare Conspiracy, the answer lies in Marlowe’s suspicious murder and the unmarked grave, which has never been found to this day. If Marlowe’s death was faked, as many historians believe, the actor Shakespeare could have fronted for Marlowe. That would explain the plays that regularly appeared after 1616 when Shakespeare died. Marlowe must have outlived Shakespeare and continued to write, hiding as a fugitive in Italy, where so many of the works take place.

Bacino’s novel is billed as “The Greatest Literary Deception of All Time.” It chronicles the life that Marlowe would have lived as a fugitive, hiding not only his gay sexuality but also his identity as the actual author.

Also, researchers have found almost a hundred identical or very similar lines in the writings of Marlowe and Shakespeare. Did one person write both?

The last fifty pages of Bacino’s novel is a supplement of historical notes and data to verify the accuracy of the details in his novel.

The only argument against Marlowe being the actually author is that he was “murdered” in 1593 before Shakespeare’s writings began appearing. But Marlowe would have still been alive to write these works if his murder was faked.

Bacino’s novel, The Shakespeare Conspiracy, has been made into a stage play of the same title, which has had productions in Columbus, Fort Lauderdale, and Rockford University. The rights for the play have recently been released for amateur and college productions.

The Sydney Morning Herald put the issue succinctly: Maybe the debate over the authorship of Shakespeare’s plays…has finally been settled.

http://www.TheShakespeareConspiracy.com

CONTACT: Dr. Rufus Cadigan                                     
(815) 969 – 9065
Rufus408(at)Gmail(dot)com

Or: Ted Bacino
(760) 778 - 1030
TBacino(at)AOL(dot)com

Ted Bacino, [email protected], http://www.TheShakespeareConspiracy.com, +1 760-778-1030, [email protected]

Modal title

Ted Bacino, Author of "The Shakespeare Conspiracy
Ted Bacino, Author of "The Shakespeare Conspiracy
Ted Bacino, Author of "The Shakespeare Conspiracy

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.